{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:10:50Z","timestamp":1786666250678,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Medical Health Science and Technology Project of Zhejiang Province","award":["2025KY1338"],"award-info":[{"award-number":["2025KY1338"]}]},{"name":"the Medical Health Science and Technology Project of Zhejiang Province","award":["2022PY022"],"award-info":[{"award-number":["2022PY022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07829-2","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:47:24Z","timestamp":1751381244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel necroptosis related prognostic signature for skin cutaneous melanoma based on transcriptome and single cell sequencing analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Xin","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"7829_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L. et al. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"7829_CR2","doi-asserted-by":"publisher","first-page":"e505","DOI":"10.1200\/EDBK_159087","volume":"35","author":"AC van Akkooi","year":"2016","unstructured":"van Akkooi, A. C. et al. Surgical management and adjuvant therapy for high-risk and metastatic melanoma. Am. Soc. Clin. Oncol. Educ. Book. 35, e505\u2013514 (2016).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"7829_CR3","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1200\/EDBK_239283","volume":"39","author":"M Yushak","year":"2019","unstructured":"Yushak, M. et al. Approaches to high-risk resected stage II and III melanoma. Am. Soc. Clin. Oncol. Educ. Book. 39 e207\u2013e211. (2019).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"7829_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1200\/EDBK_199047","volume":"38","author":"PA Ascierto","year":"2018","unstructured":"Ascierto, P. A., Flaherty, K. & Goff, S. Emerging strategies in systemic therapy for the treatment of melanoma. Am. Soc. Clin. Oncol. Educ. Book. 38, 751\u2013758 (2018).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"7829_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong, Y. et al. The role of necroptosis in cancer biology and therapy. Mol. Cancer. 18, 100 (2019).","journal-title":"Mol. Cancer"},{"key":"7829_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mco2.108","volume":"2","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. The role of necroptosis in disease and treatment. MedComm 2, 730\u2013755 (2021).","journal-title":"MedComm"},{"key":"7829_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang, R. et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J. Hematol. Oncol. 13, 110 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"7829_CR8","doi-asserted-by":"crossref","unstructured":"Negroni, A. et al. Necroptosis in intestinal inflammation and cancer: new concepts and therapeutic perspectives. Biomolecules 10 (2020).","DOI":"10.20944\/preprints202009.0084.v1"},{"key":"7829_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-023-06068-5","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Clinical-mediated discovery of pyroptosis in CD8(+) T cell and NK cell reveals melanoma heterogeneity by single-cell and bulk sequence. Cell. Death Dis. 14, 553 (2023).","journal-title":"Cell. Death Dis."},{"key":"7829_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"7829_CR11","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M. et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"7829_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"7829_CR13","doi-asserted-by":"crossref","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief. Bioinform 22 (2021).","DOI":"10.1093\/bib\/bbab260"},{"key":"7829_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11912-023-01385-6","volume":"25","author":"JP Pham","year":"2023","unstructured":"Pham, J. P. et al. Chemotherapy in cutaneous melanoma: is there still a role?? Curr. Oncol. Rep. 25, 609\u2013621 (2023).","journal-title":"Curr. Oncol. Rep."},{"key":"7829_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi, E. & Satija, R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat. Rev. Immunol. 18, 35\u201345 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"7829_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-021-01874-1","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Single-cell RNA sequencing in cancer research. J. Exp. Clin. Cancer Res. 40, 81 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"7829_CR17","doi-asserted-by":"crossref","unstructured":"Yang, K. et al. Current molecular markers of melanoma and treatment targets. Int. J. Mol. Sci. 21 (2020).","DOI":"10.3390\/ijms21103535"},{"key":"7829_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"HA Tawbi","year":"2022","unstructured":"Tawbi, H. A. et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N. Engl. J. Med. 386, 24\u201334 (2022).","journal-title":"N. Engl. J. Med."},{"key":"7829_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier, P. et al. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat. Rev. Cancer. 24, 299\u2013315 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"7829_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-024-01963-7","volume":"23","author":"K Liu","year":"2024","unstructured":"Liu, K. et al. A review of the clinical efficacy of FDA-approved antibody\u2013drug conjugates in human cancers. Mol. Cancer. 23, 62 (2024).","journal-title":"Mol. Cancer"},{"key":"7829_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12672-022-00477-2","volume":"13","author":"J Ma","year":"2022","unstructured":"Ma, J. et al. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance. Discov Oncol. 13, 17 (2022).","journal-title":"Discov Oncol."},{"key":"7829_CR22","doi-asserted-by":"publisher","first-page":"852803","DOI":"10.3389\/fonc.2022.852803","volume":"12","author":"Z Niu","year":"2022","unstructured":"Niu, Z. et al. Development and validation of a novel survival model for cutaneous melanoma based on necroptosis-related genes. Front. Oncol. 12, 852803 (2022).","journal-title":"Front. Oncol."},{"key":"7829_CR23","doi-asserted-by":"publisher","first-page":"917007","DOI":"10.3389\/fgene.2022.917007","volume":"13","author":"B Song","year":"2022","unstructured":"Song, B. et al. A novel necroptosis-related gene signature in skin cutaneous melanoma prognosis and tumor microenvironment. Front. Genet. 13, 917007 (2022).","journal-title":"Front. Genet."},{"key":"7829_CR24","doi-asserted-by":"crossref","unstructured":"Cao, X. et al. Comprehensive analysis of necroptosis landscape in skin cutaneous melanoma for appealing its implications in prognosis Estimation and microenvironment status. J. Pers. Med. 13 (2023).","DOI":"10.3390\/jpm13020245"},{"key":"7829_CR25","doi-asserted-by":"publisher","first-page":"1424385","DOI":"10.3389\/fimmu.2024.1424385","volume":"15","author":"N Liu","year":"2024","unstructured":"Liu, N. et al. TUFM in health and disease: exploring its multifaceted roles. Front. Immunol. 15, 1424385 (2024).","journal-title":"Front. Immunol."},{"key":"7829_CR26","first-page":"2105","volume":"73","author":"K He","year":"2016","unstructured":"He, K. et al. TUFM downregulation induces epithelial-mesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPK-GSK3\u03b2 signaling, cell mol. Life Sci. 73, 2105\u20132121 (2016).","journal-title":"Life Sci."},{"key":"7829_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3892\/ol.2020.12113","volume":"20","author":"X Weng","year":"2020","unstructured":"Weng, X. et al. TUFM-knockdown inhibits the migration and proliferation of gastrointestinal stromal tumor cells. Oncol. Lett. 20, 250 (2020).","journal-title":"Oncol. Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07829-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07829-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07829-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:47:28Z","timestamp":1751381248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07829-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7829"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07829-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20650"}}